OP0132 EFFECT OF IBERDOMIDE ON CUTANEOUS MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS OF A 24-WEEK, PLACEBO-CONTROLLED, PHASE 2 STUDYVictoria P. Werth, Nikolay Delev, Richard Furie et al.|Annals of the Rheumatic Diseases|2021Cited by 8